Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
3.115
+0.055 (1.80%)
May 28, 2026, 2:43 PM EDT - Market open
Genelux Market Cap
Genelux has a market cap or net worth of $138.33 million as of May 28, 2026. Its market cap has increased by 33.40% in one year.
Market Cap
138.33M
Enterprise Value
114.40M
1-Year Change
33.40%
Ranking
Category
Stock Price
$3.12
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $138.33M, a decrease of -2.37%. That is a compound annual growth rate of -0.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 135.89M | -17.15% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 149.87M |
| Indaptus Therapeutics | 143.82M |
| Agenus | 141.65M |
| Kazia Therapeutics | 138.95M |
| Corbus Pharmaceuticals Holdings | 138.70M |
| Fractyl Health | 136.31M |
| Connect Biopharma Holdings | 135.65M |
| Spruce Biosciences | 133.82M |